412 related articles for article (PubMed ID: 17916101)
1. The management of antenatal venous thromboembolism in the UK and Ireland: a prospective multicentre observational survey.
Voke J; Keidan J; Pavord S; Spencer NH; Hunt BJ;
Br J Haematol; 2007 Nov; 139(4):545-58. PubMed ID: 17916101
[TBL] [Abstract][Full Text] [Related]
2. A risk score for the management of pregnant women with increased risk of venous thromboembolism: a multicentre prospective study.
Dargaud Y; Rugeri L; Vergnes MC; Arnuti B; Miranda P; Negrier C; Bestion A; Desmurs-Clavel H; Ninet J; Gaucherand P; Rudigoz RC; Berland M; Champion F; Trzeciak MC
Br J Haematol; 2009 Jun; 145(6):825-35. PubMed ID: 19388925
[TBL] [Abstract][Full Text] [Related]
3. Low-molecular-weight heparin (LMWH) in the treatment of thrombosis.
Holzheimer RG
Eur J Med Res; 2004 Apr; 9(4):225-39. PubMed ID: 15210403
[TBL] [Abstract][Full Text] [Related]
4. [Thromboprophylaxis during pregnancy and the puerperium: highlights from current guidelines].
Rath W
Z Geburtshilfe Neonatol; 2010 Dec; 214(6):217-28. PubMed ID: 21207321
[TBL] [Abstract][Full Text] [Related]
5. Venous thromboembolism during pregnancy or postpartum: findings from the RIETE Registry.
Blanco-Molina A; Trujillo-Santos J; Criado J; Lopez L; Lecumberri R; Gutierrez R; Monreal M;
Thromb Haemost; 2007 Feb; 97(2):186-90. PubMed ID: 17264945
[TBL] [Abstract][Full Text] [Related]
6. Management and adherence to VTE treatment guidelines in a national prospective cohort study in the Canadian outpatient setting. The Recovery Study.
Kahn SR; Springmann V; Schulman S; Martineau J; Stewart JA; Komari N; McLeod A; Strulovitch C; Blostein M; Faucher JP; Gamble G; Gordon W; Kagoma PK; Miron MJ; Laverdière D; Game M; Mills A
Thromb Haemost; 2012 Sep; 108(3):493-8. PubMed ID: 22782073
[TBL] [Abstract][Full Text] [Related]
7. Meta-analysis of venous thromboembolism prophylaxis in medically Ill patients.
Kanaan AO; Silva MA; Donovan JL; Roy T; Al-Homsi AS
Clin Ther; 2007 Nov; 29(11):2395-405. PubMed ID: 18158080
[TBL] [Abstract][Full Text] [Related]
8. Recommendations for the diagnosis and treatment of deep venous thrombosis and pulmonary embolism in pregnancy and the postpartum period.
McLintock C; Brighton T; Chunilal S; Dekker G; McDonnell N; McRae S; Muller P; Tran H; Walters BN; Young L; ;
Aust N Z J Obstet Gynaecol; 2012 Feb; 52(1):14-22. PubMed ID: 21972999
[TBL] [Abstract][Full Text] [Related]
9. Low-molecular-weight heparins for the prevention and treatment of venous thromboembolism in at-risk pregnant women: a review.
Duhl AJ
J Reprod Med; 2008 Sep; 53(9):657-66. PubMed ID: 18839817
[TBL] [Abstract][Full Text] [Related]
10. Prevention of venous thromboembolism in pregnancy.
Greer IA
Eur J Med Res; 2004 Mar; 9(3):135-45. PubMed ID: 15096324
[TBL] [Abstract][Full Text] [Related]
11. A case series of LMWH use in pregnancy: should trough anti-Xa levels guide dosing?
Berresheim M; Wilkie J; Nerenberg KA; Ibrahim Q; Bungard TJ
Thromb Res; 2014 Dec; 134(6):1234-40. PubMed ID: 25450535
[TBL] [Abstract][Full Text] [Related]
12. Venous thromboembolism in pregnancy: diagnosis, management and prevention.
Chunilal SD; Bates SM
Thromb Haemost; 2009 Mar; 101(3):428-38. PubMed ID: 19277402
[TBL] [Abstract][Full Text] [Related]
13. The management of thrombosis in pregnancy: role of low-molecular-weight heparin.
Kher A; Bauersachs R; Nielsen JD
Thromb Haemost; 2007 Apr; 97(4):505-13. PubMed ID: 17393011
[TBL] [Abstract][Full Text] [Related]
14. Venous thromboembolism in pregnancy.
James AH
Arterioscler Thromb Vasc Biol; 2009 Mar; 29(3):326-31. PubMed ID: 19228606
[TBL] [Abstract][Full Text] [Related]
15. Prevention and management of venous thromboembolism in pregnancy.
James AH
Am J Med; 2007 Oct; 120(10 Suppl 2):S26-34. PubMed ID: 17916457
[TBL] [Abstract][Full Text] [Related]
16. [Low-molecular-weight heparin in the prevention of thromboembolism in pregnant thrombophilic patients].
Boda Z; László P; Rejtö L; Tornai I; Pfliegler G; Rák K
Orv Hetil; 1996 Jan; 137(4):183-5. PubMed ID: 8721833
[TBL] [Abstract][Full Text] [Related]
17. Extended thromboprophylaxis with low-molecular-weight heparins after hospital discharge in high-risk surgical and medical patients: a review.
Huo MH; Muntz J
Clin Ther; 2009 Jun; 31(6):1129-41. PubMed ID: 19695383
[TBL] [Abstract][Full Text] [Related]
18. Treatment of venous thromboembolism in patients with cancer: subgroup analysis of the Matisse clinical trials.
van Doormaal FF; Raskob GE; Davidson BL; Decousus H; Gallus A; Lensing AW; Piovella F; Prins MH; Büller HR
Thromb Haemost; 2009 Apr; 101(4):762-9. PubMed ID: 19350123
[TBL] [Abstract][Full Text] [Related]
19. Management of pregnant women with mechanical heart valve prosthesis: thromboprophylaxis with low molecular weight heparin.
Abildgaard U; Sandset PM; Hammerstrøm J; Gjestvang FT; Tveit A
Thromb Res; 2009 Jul; 124(3):262-7. PubMed ID: 19162303
[TBL] [Abstract][Full Text] [Related]
20. Anti-factor Xa plasma levels in pregnant women receiving low molecular weight heparin thromboprophylaxis.
Fox NS; Laughon SK; Bender SD; Saltzman DH; Rebarber A
Obstet Gynecol; 2008 Oct; 112(4):884-9. PubMed ID: 18827132
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
